Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
As of June 30, 2026, the company holds $28.4 million in cash and cash equivalents, ensuring financial stability until mid-2027. Progress has been made in advancing Chemistry, Manufacturing, and Controls (CMC) work towards the NDA resubmission.